Onconova Therapeutics Inc. | Mutual Funds
Mutual Funds that own Onconova Therapeutics Inc.
Vanguard Extended Market Index Fund
199,098
0.23%
0
0%
07/31/2018
Vanguard Total Stock Market Index Fund
187,984
0.22%
0
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
181,061
0.21%
0
0%
07/31/2018
Fidelity Nasdaq Composite Index
141,383
0.17%
0
0%
07/31/2018
20,740
0.02%
0
0.03%
09/05/2018
Vanguard Balanced Index Fund
6,224
0.01%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
3,480
0%
0
0%
07/31/2018
Kinetics Medical Portfolio
2,400
0%
0
0.01%
06/29/2018
Fidelity Spartan Total Market Index Fund
624
0%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
460
0%
0
0%
09/06/2018
| Address |
375 Pheasant Run
Newtown Pennsylvania 18940
United States
|
|
Employees
|
- |
| Website |
http://www.onconova.com |
| Updated |
07/08/2019 |
| Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. |
